Dec 21, 2008 12:38 PM in Society & Policy | 1 comments
Obama names Holdren, Lubchenco, Varmus and Lander to science posts
By Ivan Oransky
President-elect Barack Obama named four top science advisors in his radio address yesterday. As reported widely last week, John Holdren will be his chief science adviser, as director of the White House Office of Science and Technology, and Jane Lubchenco, a professor of marine biology at Oregon State University, will direct the National Oceanic and Atmospheric Administration.
Lubchenco, 61, will be the first woman to hold the NOAA post if she is confirmed by the Senate. As the Washington Post noted last week, she has been an outspoken critic of NOAA, saying they do not do enough to prevent overfishing. Holdren advised Obama during the presidential campaign and directs of the program on science, technology, and public policy at Harvard's Kennedy School of Government. Taken together with Obama's choice of Steven Chu as secretary of energy, the appointments suggest that Obama's stance on climate change will be significantly different from that of his predecessor.
Obama also named the chairs of the Presidential Council of Advisers on Science and Technology yesterday: Nobel Prize winner Harold Varmus and MIT genome biologist Eric Lander.
Varmus, who turned 69 last week, shared the 1989 Nobel for the discovery of viral genes that cause cancer and has had Obama's ear on science. He is the president of the Memorial Sloan Kettering Cancer Center in New York. He has also been a staunch supporter of the open access movement, which gives the public access to published research, and has called for a global science corps, similar to the Peace Corps, in which scientists would spend time in the developing world.
From 1993 until 2000, Varmus was director of the National Institutes of Health, where he loosened conflict of interest rules to make it easier for the agency to attract top scientists, a move that some say paved the way for later significant breaches in which some NIH scientists earned hundreds of thousands of dollars from drug companies. Following investigations in 2003 by the Los Angeles Times and members of Congress into such deals, Varmus later backed limiting the deals such scientists could make.
Lander, 51, was a major player in the Human Genome Project. Both he and Varmus support increased funding for scientific research. (Listen to Varmus describe his feelings on the Bush administration's science policies in a 2006 episode of Science Talk.)
Photo of Jane Lubchenco courtesy of the Obama-Biden Transition Project
Read More About: climate change, holdren, varmus, lander, obama, lubchenco, stem cells, chu
You Might Also Like
Discuss This Article
Subscription Center
Most Popular Blog Posts
9,000-year-old brew hitting the shelves this summer
New solar-cell efficiency record set
AIDS vaccine surprises scientists, proves partially successful
Is birth control the answer to environmental ills?
Editor's Pick
-
Adapting to the Freshwater CrisisForward-thinking experts are getting a better handle on the growing global water shortage and coming up with innovative approaches to ensuring the security, safety and sustainability of this resource
Society & Policy Newsletter
Get weekly coverage delivered to your inboxPodcasts
-
60-Second Earth
RSS ·
iTunes
The Jellyfish Menace
click to enable
-
60-Second Science
RSS ·
iTunes
Plants Share Light If Neighbor Is Related
click to enable
Slideshows
Researchers Try to Solve the Mystery of HIV Carriers Who Don't Contract AIDS
War Is Peace: Can Science Fight Media Disinformation?
Foreign Afflictions: Mental Disorders across Country Borders
Skate punk'd: Taxonomic "oops" put rare fish species in danger of extinction
Fight to protect California condors from lead ammunition moves to Arizona
Circulation of LHC Beams Could Resume in Earnest over the Weekend
Measuring Up: New NIST Director, Plus Big Budget Put Measurement Science in Public Eye
How Long Can a Nuclear Reactor Last?
What to Do About Endocrine Disruptors? A Q&A with Linda Birnbaum



